Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2019

01-02-2019 | Research Article

Impact of deprescribing rounds on discharge prescriptions: an interventional trial

Authors: Rachel Edey, Nicholas Edwards, Jonah Von Sychowski, Ajay Bains, Jim Spence, Dan Martinusen

Published in: International Journal of Clinical Pharmacy | Issue 1/2019

Login to get access

Abstract

Background Successful deprescribing practices are required to address issues associated with polypharmacy but are hindered by minimal interprofessional collaboration, time constraints, concern for negative outcomes, and absence of a systematic and evidence-based approach. Objective Determine the impact of pharmacist-led deprescribing rounds within a clinical teaching unit (CTU) the number of home medications discontinued upon hospital discharge. Setting Canadian tertiary care hospital. Methods Prospective, dual-arm, interventional study conducted in a single centre, from November 23rd, 2015 to August 30th, 2016. All patients ≥ 19 years old admitted under the CTU were considered for enrolment if on medication(s) prior to admission and patients were excluded if not taking any medications. Study arm allocation alternated daily between the two teams. The control arm operated as per standard whereas the intervention arm’s pharmacist used a deprescribing guide and medication review to identify medications eligible for discontinuation prior to discussing during daily rounds. Discharge documents communicated medication changes to patient and primary healthcare providers. The study was sufficiently powered. Main outcome measure The difference of number of home medications discontinued at discharge between the intervention and control groups. Results 171 and 187 patients were allocated to the intervention and control arms, respectively. No significant differences of baseline characteristics existed between groups. Main outcome measure results showed that deprescribing rounds resulted in significantly more medications deprescribed compared to control (65% vs. 38%; p = 0.001). The rates of readmission and emergency department visits were reduced in the intervention arm. Conclusions Incorporating deprescribing rounds into routine care led to significantly greater discontinuation of medications without increasing rate of emergency department visits or hospital admissions.
Trial registration ISRCTN11751440
Appendix
Available only for authorised users
Literature
2.
go back to reference Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.CrossRefPubMed Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.CrossRefPubMed
3.
go back to reference Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process: patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.CrossRefPubMedPubMedCentral Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process: patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.CrossRefPubMedPubMedCentral
4.
go back to reference O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Cullinan S, O’Sullivan R, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–81.CrossRefPubMed O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Cullinan S, O’Sullivan R, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–81.CrossRefPubMed
6.
go back to reference Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827.CrossRefPubMed Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827.CrossRefPubMed
7.
go back to reference Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm. 2013;66(3):201–2.PubMedPubMedCentral Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm. 2013;66(3):201–2.PubMedPubMedCentral
8.
go back to reference Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K. What are priorities for deprescribing in elderly patients? capturing the voice of practitioners: a modified Delphi process. PLoS. 2015;10:1–16. Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K. What are priorities for deprescribing in elderly patients? capturing the voice of practitioners: a modified Delphi process. PLoS. 2015;10:1–16.
10.
go back to reference Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis: effect of deprescribing in older adults on mortality and health. Br J Clin Pharmacol. 2016;82(3):583–623.CrossRefPubMedPubMedCentral Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis: effect of deprescribing in older adults on mortality and health. Br J Clin Pharmacol. 2016;82(3):583–623.CrossRefPubMedPubMedCentral
12.
go back to reference Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014;201(7):386–9.CrossRefPubMed Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014;201(7):386–9.CrossRefPubMed
14.
go back to reference Gnjidic D, Couteur DGL, Hilmer SN. Discontinuing drug treatments. BMJ. 2014;21(349):7013.CrossRef Gnjidic D, Couteur DGL, Hilmer SN. Discontinuing drug treatments. BMJ. 2014;21(349):7013.CrossRef
15.
go back to reference Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53.CrossRefPubMed Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53.CrossRefPubMed
16.
go back to reference Howland RH. Deprescribing to reduce medication use: will this help your patient? J Psychosoc Nurs Ment Health Serv. 2016;54(11):21–4.CrossRefPubMed Howland RH. Deprescribing to reduce medication use: will this help your patient? J Psychosoc Nurs Ment Health Serv. 2016;54(11):21–4.CrossRefPubMed
17.
go back to reference Reeve E, Wiese MD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26–9.CrossRefPubMed Reeve E, Wiese MD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26–9.CrossRefPubMed
18.
go back to reference Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.CrossRefPubMed Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.CrossRefPubMed
19.
go back to reference Anderson K, Freeman C, Rowett D, Burrows J, Scott I, Rigby D. Polypharmacy, deprescribing and shared decision-making in primary care: the role of the accredited pharmacist: the role of the accredited pharmacist. J Pharm Pract Res. 2015;45(4):446–9.CrossRef Anderson K, Freeman C, Rowett D, Burrows J, Scott I, Rigby D. Polypharmacy, deprescribing and shared decision-making in primary care: the role of the accredited pharmacist: the role of the accredited pharmacist. J Pharm Pract Res. 2015;45(4):446–9.CrossRef
20.
go back to reference Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;1(38):3–11.CrossRef Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;1(38):3–11.CrossRef
21.
go back to reference Harriman K, Howard L, McCracken L. Deprescribing medication for frail elderly patients in nursing homes: a survey of Vancouver family physicians. BCMJ. 2014;56(9):436–41. Harriman K, Howard L, McCracken L. Deprescribing medication for frail elderly patients in nursing homes: a survey of Vancouver family physicians. BCMJ. 2014;56(9):436–41.
22.
go back to reference Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.CrossRefPubMed Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.CrossRefPubMed
23.
go back to reference Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.PubMed Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9(6):430–4.PubMed
25.
go back to reference Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–8.CrossRef Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–8.CrossRef
26.
go back to reference Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis: impact of strategies to reduce polypharmacy. Br J Clin Pharmacol. 2016;82(2):532–48.CrossRefPubMedPubMedCentral Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis: impact of strategies to reduce polypharmacy. Br J Clin Pharmacol. 2016;82(2):532–48.CrossRefPubMedPubMedCentral
28.
go back to reference Linsky A, Simon SR, Stolzmann K, Meterko M. Patient perceptions of deprescribing (PPoD): survey development and psychometric assessment. Med Care. 2016;55:306–13.CrossRef Linsky A, Simon SR, Stolzmann K, Meterko M. Patient perceptions of deprescribing (PPoD): survey development and psychometric assessment. Med Care. 2016;55:306–13.CrossRef
29.
go back to reference Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. Quinn TJ, editor. PLoS ONE. 2016;11(8):e0161248.CrossRefPubMedPubMedCentral Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. Quinn TJ, editor. PLoS ONE. 2016;11(8):e0161248.CrossRefPubMedPubMedCentral
30.
go back to reference McKean M, Pillans P, Scott IA. A medication review and deprescribing method for hospitalised older patients receiving multiple medications: deprescribing in older patients. Intern Med J. 2016;46(1):35–42.CrossRefPubMed McKean M, Pillans P, Scott IA. A medication review and deprescribing method for hospitalised older patients receiving multiple medications: deprescribing in older patients. Intern Med J. 2016;46(1):35–42.CrossRefPubMed
Metadata
Title
Impact of deprescribing rounds on discharge prescriptions: an interventional trial
Authors
Rachel Edey
Nicholas Edwards
Jonah Von Sychowski
Ajay Bains
Jim Spence
Dan Martinusen
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0753-2

Other articles of this Issue 1/2019

International Journal of Clinical Pharmacy 1/2019 Go to the issue